Post GATT ERA of Pharmaceutical R&D in India

Abstract: Ever since the advent of GATT and WTO, of which India has been a signatory and member, there has been an increasing need to join the global race, Indian industry in the shortest possible time should rise from a process development R&D culture to one that leads to basic discovery and development of new drugs. The country's policy makers respect the need to provide maximum support to the industry and government-funded national laboratories, to meet the challenges of the so-called post- 2005 era, when a globally harmonized patent system will prohibit the production and marketing of patent-protected new drugs except by the patentee or his licensee. Post 2005 era is thus era of arrival of MNCs in Indian R&D market, and is an era of arousal of Indian pharmaceutical companies in field of new drug development.

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com